AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy.
about
Vascular endothelial growth factor-B in physiology and diseaseVascular Endothelial Growth Factor-B Induces a Distinct Electrophysiological Phenotype in Mouse Heart.Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.Mouse ECG findings in aging, with conduction system affecting drugs and in cardiac pathologies: Development and validation of ECG analysis algorithm in mice.Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injuryVEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.Intercellular communication lessons in heart failure.Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons.Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney.Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart.VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications.Peroxisome proliferator-activated receptor-γ coactivator 1 α1 induces a cardiac excitation-contraction coupling phenotype without metabolic remodelling.New vascular endothelial growth factor isoforms promise to increase myocardial perfusion without stealing.Vascular Endothelial Growth Factor B and Its Signaling.
P2860
Q27003400-B3C15DD4-C047-49E1-AA90-C93AB7AA2D53Q33743164-EB5E9D3F-F9A2-4F7F-AE6B-435ADA54226EQ35995921-4A7F1F7A-6ECD-4644-B3A8-3BC685925FB7Q36597856-9633774A-5DF1-4EAE-A213-76585DF060E1Q36865307-23930C1A-B2CA-4557-A2FF-322F355C268AQ37644376-3B631D19-F7FA-44CC-883F-8BB85D9971A8Q38591546-1F1FFC6C-5125-4900-BD02-B48D2539905EQ38835689-2F6A82D8-FD88-4C39-8313-CD7CC5EE8A74Q39284965-D82AD269-2356-4C50-8571-DAE9AF712308Q39958821-5AB4ADC8-4962-42E3-95EB-A6BAECEAE6D3Q41021093-99F9FE81-FF2C-409C-85B8-4878F7EA798CQ42491822-C6CD9682-4DD0-4920-A52B-196FA8916E21Q51417816-2015CAF1-973D-4856-9665-7F540D9EE5EAQ54682408-CB0BC261-7F2B-4971-84E2-33046B27C8DFQ55379904-A9DB3B97-191B-4468-B0D2-D7A713109C4A
P2860
AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
AAV9-mediated VEGF-B gene tran ...... left ventricular hypertrophy.
@ast
AAV9-mediated VEGF-B gene tran ...... left ventricular hypertrophy.
@en
type
label
AAV9-mediated VEGF-B gene tran ...... left ventricular hypertrophy.
@ast
AAV9-mediated VEGF-B gene tran ...... left ventricular hypertrophy.
@en
prefLabel
AAV9-mediated VEGF-B gene tran ...... left ventricular hypertrophy.
@ast
AAV9-mediated VEGF-B gene tran ...... left ventricular hypertrophy.
@en
P2093
P2860
P356
P1433
P1476
AAV9-mediated VEGF-B gene tran ...... left ventricular hypertrophy.
@en
P2093
Andrey Anisimov
Atsushi Miyanohara
Erika Gurzeler
Jenni Huusko
Line Lottonen
Mari Merentie
P2860
P304
P356
10.1038/MT.2012.145
P577
2012-10-23T00:00:00Z